Showing 41 - 60 results of 67,353 for search '(( e mean decrease ) OR ((( 5 ht decrease ) OR ( 5 ((nmon decrease) OR (a decrease)) ))))', query time: 0.84s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44

    Additional Analysis of visually induced calcium transients in Fig 5. by Maureen M. Sampson (9322886)

    Published 2020
    “…<p>Visually induced calcium transients were recorded in flies expressing L2-split-GAL4>GCaMP6f as in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009003#pgen.1009003.g005" target="_blank">Fig 5</a>. …”
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49

    Additional Analysis of visually induced calcium transients in Fig 6. by Maureen M. Sampson (9322886)

    Published 2020
    “…<p>Visually induced calcium transients were recorded in 5-HT2B +/- or 5-HT2B -/- flies as described in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009003#pgen.1009003.g006" target="_blank">Fig 6</a>. …”
  10. 50

    Serotonin modulates L2 neuron visually induced calcium transient kinetics. by Maureen M. Sampson (9322886)

    Published 2020
    “…Shaded areas show mean +/- SEM. Comparisons are two-way repeated measures ANOVA with the bracket in 5C’ indicating a significant effect of genotype (p≤0.05*).…”
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56

    Structure-Based Design of a Chemical Probe Set for the 5‑HT<sub>5A</sub> Serotonin Receptor by Anat Levit Kaplan (12126567)

    Published 2022
    “…Docking over 6 million molecules against a 5-HT<sub>5A</sub>R homology model identified 5 mid-μM ligands, one of which was optimized to <b>UCSF678</b>, a 42 nM arrestin-biased partial agonist at the 5-HT<sub>5A</sub>R with a more restricted off-target profile and decreased assay liabilities versus SB-699551. …”
  17. 57

    Structure-Based Design of a Chemical Probe Set for the 5‑HT<sub>5A</sub> Serotonin Receptor by Anat Levit Kaplan (12126567)

    Published 2022
    “…Docking over 6 million molecules against a 5-HT<sub>5A</sub>R homology model identified 5 mid-μM ligands, one of which was optimized to <b>UCSF678</b>, a 42 nM arrestin-biased partial agonist at the 5-HT<sub>5A</sub>R with a more restricted off-target profile and decreased assay liabilities versus SB-699551. …”
  18. 58
  19. 59
  20. 60